1. Diehl JT, Cali RF, Hertzer NR, Beven EG. Complications of abdominal aortic reconstruction. An analysis of perioperative risk factors in 557 patients. Ann Surg. 1983. 197:49–56.
Article
2. Antonucci F, Bertolissi M, Calo L. Plasma endothelin and renal function during infrarenal aortic crossclamping and nifedipine infusion. Lancet. 1990. 336:1449.
Article
3. Birch RF, Lake CL. Pro: magnesium is a valuable therapy in the cardiac surgical patient. J Cadiothorac Vasc Anesth. 1991. 5:518–521.
4. Altura BM, Altura BT, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science. 1983. 221:376–378.
Article
5. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium. 1985. 4:245–271.
6. Liao JC, Lijima T, Palahnuik RJ. Effect of magnesium sulfate on hemodynamic and reflex sympathetic vasoconstriction. Anesthesiology. 1990. 73:A942.
7. James MF. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth. 1989. 62:616–623.
Article
8. Iseri LT, Allen BJ, Brodsky MA. Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium. 1989. 8:299–306.
9. Telci L, Esen F, Akcora D, Erden T, Canbolat AT, Akpir K. Evaluation of effects of magnesium sulphate in reducing intraoperative anaesthetic requirements. Br J Anaesth. 2002. 89:594–598.
Article
10. Buvanendran A, McCarthy RJ, Kroin JS, Leong W, Perry P, Tuman KJ. Intrathecal magnesium prolongs fentanyl analgesia: a prospective, randomized, controlled trial. Anesth Analg. 2002. 95:661–666.
Article
11. James MF, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg. 1989. 68:772–776.
Article
12. Kraus T, Klar E, Osswald BR, Fernandes L, Mehrabi A, Gebhard MM, Herfarth C. Continuous measurement of porcine renal cortex microcirculation with enhanced thermal diffusion technology. J Surg Res. 1996. 61:531–536.
Article
13. Martin GT, Bowman HF. Validation of real-time continuous perfusion measurement. Med Biol Eng Comput. 2000. 38:319–325.
Article
14. Bicknell CD, Cowan AR, Kerle MI, Mansfield AO, Cheshire NJ, Wolfe JH. Renal dysfunction and prolonged visceral ischaemia increase mortality rate after suprarenal aneurysm repair. Br J Surg. 2003. 90:1142–1146.
Article
15. Cherr GS, Hansen KJ. Renal complications with aortic surgery. Semin Vasc Surg. 2001. 14:245–254.
Article
16. Sheinbaum R, Ignacio C, Safi HJ, Estrera A. Contemporary strategies to preserve renal function during cardiac and vascular surgery. Rev Cardiovasc Med. 2003. 4:S21–S28.
17. Jacobs MJ, Eijsman L, Meylaerts SA, Balm R, Legemate DA, de Haan P, Kalkman CJ, de Mol BA. Reduced renal failure following thoracoabdominal aortic aneurysm repair by selective perfusion. Eur J Cardiothorac Surg. 1998. 14:201–205.
18. Gilbert TB, Hasnain JU, Flinn WR, Lilly MP, Benjamin ME. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. J Cardiovasc Pharmacol Ther. 2001. 6:31–36.
Article
19. Reiher L, Vosberg H, Sandmann W. Kidney protection in preventing post-ischaemic renal failure during thoracoabdominal aortic aneurysm repair: does prostaglandin E1 together with cooling provide more protection than cooling alone? Vasa. 2001. 30:21–23.
20. James MF. Clinical use of magnesium infusions in anesthesia. Anesth Analg. 1992. 74:129–136.
Article
21. Backlund M, Pere P, Lepantalo M, Lehtola A, Lindgren L. Effect of intra-aortic magnesium on renal function during and after abdominal aortic surgery: a pilot study. Acta Anaesthesiol Scand. 2000. 44:605–611.
22. Choi JC, Yoon KB, Um DJ, Kim C, Kim JS, Lee SG. Intravenous magnesium sulfate administration reduces propofol infusion requirements during maintenance of propofol-N2O anesthesia: part I: comparing propofol requirements according to hemodynamic responses: part II: comparing bispectral index in control and magnesium groups. Anesthesiology. 2002. 97:1137–1141.
23. Kroin JS, McCarthy RJ, Von Roenn N, Schwab B, Tuman KJ, Ivankovich AD. Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg. 2000. 90:913–917.
Article
24. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium on humans. Hypertension. 1987. 9:379–383.
25. Poulsen EU, Jorgensen JO, Madsen FF, Djurhuus JC. Cortical blood flow in the porcine kidney. A radioactive microsphere study. Urol Res. 1988. 116:385–387.
26. Lonard BL, Malpas SC, Denton KM, Madden AC, Evans RG. Differential control of intrarenal blood flow during reflex increases in sympathetic nerve activity. Am J Physiol Integr Comp Physiol. 2001. 280:R62–R68.
27. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med. 2003. 31:2509–2513.
Article
28. Mroczek WJ, Lee WR, Davidov ME. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology. 1977. 28:720–724.
Article